Bibliography and Further ReadingChapter 1: Designer Drugs and the BrainBuchanan, J.F., and C.R. Brown. “‘Designer drugs.’ A problem in clinical toxicology.”Medical Toxicology and Adverse Drug Experience 3, 1988. 1–17.Henderson, G.L. “Designer Drugs: Past History and Future Prospects.”Journal of Forensic Science 33 (1988): 569–575.Morgan, J.P. “Designer Drugs.” In: Substance Abuse—A ComprehensiveTextbook (Lowinson JH, Ruiz P, Millman RB, Langrod JG, eds). 3 rd ed.Baltimore: Williams & Wilkins, 1997, 264–269.Ziporyn, T. “A growing industry and menace: makeshift laboratory’s designerdrugs.” Journal of the American Medical Association 256 (1986): 3061–3063.Chapter 2: MethamphetamineThe DAWN Report. Rockville, Md.: Drug Abuse Warning Network, Office ofApplied Studies, Substance Abuse and Mental Health ServicesAdministration (SAMHSA), December 2000.Emergency Department Trends from the Drug Abuse Warning Network: FinalEstimates 1994–2001, Rockville, Md.: Office of Applied Studies, SubstanceAbuse and Mental Health Services Administration (SAMHSA), August2002.Fact Sheet: Methamphetamine. Rockville, Md.: Office of National DrugControl Policy Information Clearinghouse, May 1999.Monitoring the Future 2002—Data from In-School Surveys on 8 th ,10 th and 12 thGrade Students, Rockville, Md.: National Institute on Drug Abuse and theUniversity of Michigan, December 2002.Research Report: Methamphetamine Abuse and Addiction, Bethesda, Md.:National Institute on Drug Abuse, NIH Publication 98-4210, April 1998.Chapter 3: EcstasyCole, J.C., and H.R. Sumnall. “Altered States: the Clinical Effects of Ecstasy.”Pharmacology and Therapeutics 98 (2003) 35–58.The DAWN Report. Rockville, Md.: Drug Abuse Warning Network, Office ofApplied Studies, Substance Abuse and Mental Health ServicesAdministration (SAMHSA), December 2000.Emergency Department Trends from the Drug Abuse Warning Network: FinalEstimates 1994–2001, Rockville, Md.: Office of Applied Studies, SubstanceAbuse and Mental Health Services Administration (SAMHSA), August2002.Fact Sheet: MDMA (Ecstasy). Rockville, Md.: Office of National Drug ControlPolicy Information Clearinghouse, May 1999.83
Bibliography and Further ReadingMonitoring the Future 2002—Data from In-School Surveys on 8 th ,10 th and 12 thGrade Students, Bethesda, Md.: National Institute on Drug Abuse and theUniversity of Michigan, December 2002.Chapter 4: GHBThe DAWN Report. Rockville, Md.: Drug Abuse Warning Network, Office ofApplied Studies, Substance Abuse and Mental Health ServicesAdministration (SAMHSA), December 2000.Emergency Department Trends from the Drug Abuse Warning Network: FinalEstimates 1994–2001, Rockville, Md.: Office of Applied Studies, SubstanceAbuse and Mental Health Services Administration (SAMHSA), August2002.Fact Sheet: Gamma Hydroxybutyrate. Rockville, Md.: Office of National DrugControl Policy Information Clearinghouse, November 2002.Monitoring the Future 2002—Data from In-School Surveys on 8 th ,10 th and 12 thGrade Students, Bethedsa, Md.: National Institute on Drug Abuse and theUniversity of Michigan, December 2002.Chapter 5: RohypnolThe DAWN Report. Rockville, Md.: Drug Abuse Warning Network, Office ofApplied Studies, Substance Abuse and Mental Health ServicesAdministration (SAMHSA), December 2000.Emergency Department Trends from the Drug Abuse Warning Network: FinalEstimates 1994–2001, Rockville, Md.: Office of Applied Studies, SubstanceAbuse and Mental Health Services Administration (SAMHSA), August2002.Fact Sheet: Rohypnol. Rockville, Md.: Office of National Drug Control PolicyInformation Clearinghouse, February 2003.Monitoring the Future 2001—Data from In-School Surveys on 8 th ,10 th and 12 thGrade Students, Bethesda, Md.: National Institute on Drug Abuse and theUniversity of Michigan, 2002.Chapter 6: KetamineCurran, H.V., and C. Morgan. “Cognitive, Dissociative and PsychotogenicEffects of Ketamine in Recreational Users on the Night of Drug Use and 3Days Later.” Addiction 95 (2000): 575–590.The DAWN Report. Rockville, Md.: Drug Abuse Warning Network, Officeof Applied Studies, Substance Abuse and Mental Health ServicesAdministration (SAMHSA), December 2000.84
- Page 2 and 3:
DRUGSThe Straight FactsDesignerDrug
- Page 4 and 5:
DRUGSThe Straight FactsDesignerDrug
- Page 6 and 7:
Table of ContentsThe Use and Abuse
- Page 8 and 9:
the connection between our demand f
- Page 10 and 11:
The term designer drugs was origina
- Page 12 and 13:
Designer Drugs and the Brain11may l
- Page 14 and 15:
Designer Drugs and the Brain13Figur
- Page 16 and 17:
Designer Drugs and the Brain15Other
- Page 18 and 19:
Designer Drugs and the Brain17Figur
- Page 20 and 21:
a much stronger “rush” than was
- Page 22 and 23:
Methamphetamine21Figure 2.2 Methamp
- Page 24 and 25:
Methamphetamine23known to hijack sh
- Page 26 and 27:
Methamphetamine25or hemorrhage. Chr
- Page 28 and 29:
Methamphetamine27Figure 2.4 Althoug
- Page 30 and 31:
Methamphetamine29decline in their a
- Page 32 and 33:
Figure 3.1 The chemical structure o
- Page 34 and 35: Ecstasy33Figure 3.2 Ecstasy tablets
- Page 36 and 37: Ecstasy35that felt after taking coc
- Page 38 and 39: Ecstasy37specifically in serotonin-
- Page 40 and 41: Ecstasy39parties, and raves, and it
- Page 42 and 43: Ecstasy41RAVESEcstasy and other des
- Page 44 and 45: and underground laboratories began
- Page 46 and 47: GHB45a coma-like state for which pa
- Page 48 and 49: GHB47assault to the police. In addi
- Page 50 and 51: GHB49a consequence, enforcement of
- Page 52 and 53: GHB51STATISTICS AND PATTERNS OF GHB
- Page 54 and 55: GHB53Figure 4.2 The number of emerg
- Page 56 and 57: and European countries. Rohypnol is
- Page 58 and 59: Rohypnol57Figure 5.2 The chemical s
- Page 60 and 61: Rohypnol59Rohypnol can also act dir
- Page 62 and 63: Rohypnol61Both of these are false
- Page 64 and 65: list, signifying that further restr
- Page 66 and 67: Ketamine65Figure 6.2 The chemical s
- Page 68 and 69: Ketamine67HOW KETAMINE WORKS IN THE
- Page 70 and 71: Ketamine69Figure 6.3 Although the n
- Page 72 and 73: Ketamine71the drug. As with other d
- Page 74 and 75: Figure 7.1 The opium poppy, shown h
- Page 76 and 77: Painkiller Analogues75In 1979-1980,
- Page 78 and 79: Painkiller Analogues77Figure 7.3 Th
- Page 80 and 81: Painkiller Analogues79Figure 7.4 Th
- Page 82 and 83: Painkiller Analogues81the brain tha
- Page 86 and 87: Dillon, P. Copel, and J.K. Jansen.
- Page 88 and 89: www.projectghb.orgInformation about
- Page 90 and 91: Talk With Your KidsInformation on t
- Page 92 and 93: Date rape drugsEcstasy, 37GHB, 43,
- Page 94 and 95: legal status of,18-19looks of, 19-2
- Page 96 and 97: Picture Creditspage:13: Lambda Scie